289 related articles for article (PubMed ID: 22561297)
1. Cardiac mTOR protects the heart against ischemia-reperfusion injury.
Aoyagi T; Kusakari Y; Xiao CY; Inouye BT; Takahashi M; Scherrer-Crosbie M; Rosenzweig A; Hara K; Matsui T
Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H75-85. PubMed ID: 22561297
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mTOR rescues the detrimental effects of diet-induced obesity in the heart after ischemia-reperfusion.
Aoyagi T; Higa JK; Aoyagi H; Yorichika N; Shimada BK; Matsui T
Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1530-9. PubMed ID: 25888508
[TBL] [Abstract][Full Text] [Related]
3. Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway.
Zhou Y; Fang H; Lin S; Shen S; Tao L; Xiao J; Li X
Cell Physiol Biochem; 2015; 37(2):454-64. PubMed ID: 26315320
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
[TBL] [Abstract][Full Text] [Related]
5. mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury.
Shimada BK; Yorichika N; Higa JK; Baba Y; Kobayashi M; Aoyagi T; Suhara T; Matsui T
Physiol Rep; 2021 Mar; 9(6):e14807. PubMed ID: 33769701
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG
Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229
[TBL] [Abstract][Full Text] [Related]
7. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.
Song X; Kusakari Y; Xiao CY; Kinsella SD; Rosenberg MA; Scherrer-Crosbie M; Hara K; Rosenzweig A; Matsui T
Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1256-66. PubMed ID: 20861467
[TBL] [Abstract][Full Text] [Related]
8. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.
Das A; Salloum FN; Filippone SM; Durrant DE; Rokosh G; Bolli R; Kukreja RC
Basic Res Cardiol; 2015 May; 110(3):31. PubMed ID: 25911189
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.
Zhong B; Wang DH
Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353
[TBL] [Abstract][Full Text] [Related]
11. HSPA12B Attenuated Acute Myocardial Ischemia/reperfusion Injury via Maintaining Endothelial Integrity in a PI3K/Akt/mTOR-dependent Mechanism.
Kong Q; Dai L; Wang Y; Zhang X; Li C; Jiang S; Li Y; Ding Z; Liu L
Sci Rep; 2016 Sep; 6():33636. PubMed ID: 27644317
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
Brunner F; Maier R; Andrew P; Wölkart G; Zechner R; Mayer B
Cardiovasc Res; 2003 Jan; 57(1):55-62. PubMed ID: 12504814
[TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol kinase α exacerbates cardiac injury after ischemia/reperfusion.
Sasaki T; Shishido T; Kadowaki S; Kitahara T; Suzuki S; Katoh S; Funayama A; Netsu S; Watanabe T; Goto K; Takeishi Y; Kubota I
Heart Vessels; 2014 Jan; 29(1):110-8. PubMed ID: 23719772
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death.
Qian J; Ren X; Wang X; Zhang P; Jones WK; Molkentin JD; Fan GC; Kranias EG
Circ Res; 2009 Dec; 105(12):1223-31. PubMed ID: 19850943
[TBL] [Abstract][Full Text] [Related]
16. Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury.
Fan GC; Ren X; Qian J; Yuan Q; Nicolaou P; Wang Y; Jones WK; Chu G; Kranias EG
Circulation; 2005 Apr; 111(14):1792-9. PubMed ID: 15809372
[TBL] [Abstract][Full Text] [Related]
17. Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion.
Zhai P; Sciarretta S; Galeotti J; Volpe M; Sadoshima J
Circ Res; 2011 Aug; 109(5):502-11. PubMed ID: 21737790
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-specific overexpression of an active form of Rac predisposes the heart to increased myocardial stunning and ischemia-reperfusion injury.
Talukder MA; Elnakish MT; Yang F; Nishijima Y; Alhaj MA; Velayutham M; Hassanain HH; Zweier JL
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H294-302. PubMed ID: 23161879
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of trimetazidine on myocardial ischemia/reperfusion injury through activating AMPK and ERK signaling pathway.
Liu Z; Chen JM; Huang H; Kuznicki M; Zheng S; Sun W; Quan N; Wang L; Yang H; Guo HM; Li J; Zhuang J; Zhu P
Metabolism; 2016 Mar; 65(3):122-30. PubMed ID: 26892523
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
Wang L; Quan N; Sun W; Chen X; Cates C; Rousselle T; Zhou X; Zhao X; Li J
Cardiovasc Res; 2018 May; 114(6):805-821. PubMed ID: 29409011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
